The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Morphine and alternative opioids in cancer pain: the EAPC recommendations
Open accessAbstract
An expert working group of the European Association for Palliative Care has revised and updated its guidelines on the use of morphine in the management of cancer pain. The revised recommendations presented here give guidance on the use of morphine and the alternative strong opioid analgesics which have been introduced in many parts of the world in recent years. Practical strategies for dealing with difficult situations are described presenting a consensus view where supporting evidence is lacking. The strength of the evidence on which each recommendation is based is indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breakthrough pain: definition, prevalence and characteristics
Portenoy, R. K., & Hagen, N. A. (1990) · Pain · doi:10.1016/0304-3959(90)90004-w · Cited by 933
Epidural clonidine analgesia for intractable cancer pain
Eisenach, J. C., DuPen, S., Dubois, M., Miguel, R., & Allin, D. (1995) · Pain · doi:10.1016/0304-3959(94)00209-w · Cited by 533
The WHO Analgesic Ladder for Cancer Pain Management: Stepping Up the Quality of Its Evaluation
Jadad, A. R. (1995) · JAMA · doi:10.1001/jama.1995.03530230056031 · Cited by 453
McQuay, H. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03528-x · Cited by 414
Self-citationOpioid rotation for toxicity reduction in terminal cancer patients
de Stoutz, N. D., Bruera, E., & Suarez-Almazor, M. (1995) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(95)90924-c · Cited by 382
Ripamonti, C., Groff, L., Brunelli, C., Polastri, D., Stavrakis, A., & De Conno, F. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3216 · Cited by 345
Self-citationClinical Pharmacokinetics of Morphine
Glare, P. A., & Walsh, T. D. (1991) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199101000-00001 · Cited by 290
Morphine and oxycodone hydrochloride in the management of cancer pain
Kalso, E., & Vainio, A. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.85 · Cited by 261
Self-citationDriving ability in cancer patients receiving long-term morphine analgesia
Vainio, A., Rosenberg, P., Kalso, E., Ollila, J., & Matikainen, E. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92281-4 · Cited by 220
Self-citationBruera, E., Belzile, M., Pituskin, E., Fainsinger, R., Darke, A., Harsanyi, Z., Babul, N., & Ford, I. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3222 · Cited by 204
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Caraceni, A., Hanks, G., Kaasa, S., Bennett, M. I., Brunelli, C., Cherny, N., Dale, O., De Conno, F., Fallon, M., Hanna, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70040-2 · Cited by 1,243
Self-citationPrevalence of undertreatment in cancer pain. A review of published literature
Deandrea, S., Montanari, M., Moja, L., & Apolone, G. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn419 · Cited by 870
Davies, A. N., Dickman, A., Reid, C., Stevens, A., & Zeppetella, G. (2009) · European Journal of Pain · doi:10.1016/j.ejpain.2008.06.014 · Cited by 482
Management of cancer pain: ESMO Clinical Practice Guidelines
Ripamonti, C. I., Bandieri, E., & Roila, F. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr390 · Cited by 447
Self-citationCancer pain and its impact on diagnosis, survival and quality of life
Mantyh, P. W. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1914 · Cited by 441
Addiction to opioids in chronic pain patients: A literature review
Højsted, J., & Sjøgren, P. (2007) · European Journal of Pain · doi:10.1016/j.ejpain.2006.08.004 · Cited by 424
“…the Scottish Intercollegiate Guidelines Network in 2000 (Scottish Intercollegiate Guidelines Network, 2000), and in 2001 the European Association for Palliative Care (EAPC) published recommendations concerning the use of morphine and alternative opioids in cancer related pain (Hanks et al., 2001).”
BackgroundMethodThe use of opioids and sedatives at the end of life
Sykes, N., & Thorns, A. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01079-9 · Cited by 354
Management of cancer pain: ESMO Clinical Practice Guidelines
Ripamonti, C. I., Santini, D., Maranzano, E., Berti, M., & Roila, F. (2012) · Annals of Oncology · doi:10.1093/annonc/mds233 · Cited by 329
Self-citationOpioid-induced bowel dysfunction: prevalence, pathophysiology and burden
Panchal, S. J., Müller-Schwefe, P., & Wurzelmann, J. I. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01415.x · Cited by 325
Swarm, R., Abernethy, A. P., Anghelescu, D. L., Benedetti, C., Blinderman, C. D., Boston, B., Cleeland, C., Coyle, N., deLeon-Casasola, O. A., Eilers, J. G., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0076 · Cited by 319
Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile
Pergolizzi, J., Aloisi, A. M., Dahan, A., Filitz, J., Langford, R., Likar, R., Mercadante, S., Morlion, B., Raffa, R. B., Sabatowski, R., et al. (2010) · Pain Practice · doi:10.1111/j.1533-2500.2010.00378.x · Cited by 284
Self-citationTuca, A., Guell, E., Martinez-Losada, E., & Codorniu, N. (2012) · Cancer Management and Research · doi:10.2147/cmar.s29297 · Cited by 282
Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction
Leppert, W. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s32684 · Cited by 72
Metadata
- Authors
- Hanks, G. W., Conno, F. D., Cherny, N., Hanna, M., Kalso, E., McQuay, H. J., Mercadante, S., Meynadier, J., Poulain, P., Ripamonti, C., Radbruch, L., Casas, J. R. I., Sawe, J., Twycross, R. G., & Ventafridda, V
- Venue
- British Journal of Cancer
- Published
- 2001
- Volume
- 84
- Issue
- 5
- Pages
- 587-593
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2107448778
- Cited by
- 862
- References
- 27
- FWCI
- 26.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.